{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:51:47Z","timestamp":1794963107588,"version":"4.9.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HC19C0130"],"award-info":[{"award-number":["HC19C0130"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030909","name":"Sawai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030909","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.heliyon.2024.e36506","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T19:45:11Z","timestamp":1723837511000},"page":"e36506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The anticoagulation one year after ablation of atrial fibrillation in patients with atrial fibrillation (ALONE-AF) trial: Study protocol"],"prefix":"10.1016","volume":"10","author":[{"given":"Daehoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaemin","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Young","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbeom","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jum-Suk","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hoon","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Seob","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Youn","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Tae","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9036-7225","authenticated-orcid":false,"given":"Boyoung","family":"Joung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2024.e36506_bib1","first-page":"e1","article-title":"ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36506_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.heliyon.2024.e36506_bib3","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1136\/heartjnl-2017-312930","article-title":"Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015","volume":"104","author":"Kim","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.heliyon.2024.e36506_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ahj.2018.04.017","article-title":"10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population","volume":"202","author":"Kim","year":"2018","journal-title":"Am. Heart J."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e36506_bib5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e36506_bib6","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e36506_bib7","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.heliyon.2024.e36506_bib8","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e36506_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.106.641225","article-title":"Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation","volume":"114","author":"Oral","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36506_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2459\/JCM.0b013e32801462d4","article-title":"Role of anticoagulation therapy after pulmonary vein antrum isolation for atrial fibrillation treatment","volume":"9","author":"Rossillo","year":"2008","journal-title":"J. Cardiovasc. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e36506_bib11","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1540-8167.2009.01481.x","article-title":"Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures","volume":"20","author":"Bunch","year":"2009","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e36506_bib12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jacc.2009.11.039","article-title":"The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation","volume":"55","author":"Themistoclakis","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36506_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCEP.111.963231","article-title":"Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score \u22643: a long-term outcome study, Circulation","volume":"4","author":"Saad","year":"2011","journal-title":"Arrhythmia and electrophysiology"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e36506_bib14","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1253\/circj.CJ-11-0065","article-title":"Incidence of late thromboembolic events after catheter ablation of atrial fibrillation","volume":"75","author":"Yagishita","year":"2011","journal-title":"Circ. J."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36506_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1540-8167.2011.02141.x","article-title":"Anticoagulant therapy and risk of cerebrovascular events after catheter ablation of atrial fibrillation in the elderly","volume":"23","author":"Guiot","year":"2012","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36506_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10840-013-9835-1","article-title":"Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes","volume":"38","author":"Winkle","year":"2013","journal-title":"J. Intervent. Card Electrophysiol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e36506_bib17","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/europace\/eut406","article-title":"Incidence of cerebral thromboembolic events during long-term follow-up in patients treated with transcatheter ablation for atrial fibrillation","volume":"16","author":"Gaita","year":"2014","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36506_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HCO.0000000000000121","article-title":"Long-term oral anticoagulation for patients after successful catheter ablation of atrial fibrillation: is it necessary?","volume":"30","author":"Ha","year":"2015","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e36506_bib19","article-title":"Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks","author":"Kanaoka","year":"2023","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36506_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36506_bib21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36506_bib22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ahj.2009.11.025","article-title":"Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study","volume":"159","year":"2010","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36506_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J. Thromb. Haemostasis"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36506_bib24","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J. Thromb. Haemostasis"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36506_bib25","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","volume":"40","author":"Easton","year":"2009","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36506_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCEP.110.958033","article-title":"Development and validation of the atrial fibrillation effect on QualiTy-of-life (AFEQT) questionnaire in patients with atrial fibrillation","volume":"4","author":"Spertus","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36506_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCOUTCOMES.111.963108","article-title":"Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis","volume":"5","author":"Reynolds","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e36506_bib28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36506_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/eurheartj\/ehu421","article-title":"Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark","volume":"36","author":"Karasoy","year":"2015","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e36506_bib30","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36506_bib31","first-page":"219","article-title":"Anticoagulation management pre- and post atrial fibrillation ablation: a survey of canadian centres","volume":"29","author":"Mardigyan","year":"2013","journal-title":"Can. J. Cardiol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36506_bib32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/europace\/eus105","article-title":"Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation","volume":"14","author":"Lip","year":"2012","journal-title":"Europace"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36506_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002597","article-title":"Patterns of anticoagulation use and cardioembolic risk after catheter ablation for atrial fibrillation","volume":"4","author":"Noseworthy","year":"2015","journal-title":"J. Am. Heart Assoc."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024125376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024125376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:37:07Z","timestamp":1773182227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024125376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":33,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2405844024125376"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36506","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anticoagulation one year after ablation of atrial fibrillation in patients with atrial fibrillation (ALONE-AF) trial: Study protocol","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e36506"}}